Скачать или смотреть Diabetes Innovators 04 - Scott Hebl, Medtronic Diabetes

In this conversation, Scott Hebl, Vice President for Program Management at Medtronic Diabetes, discusses the exciting innovations and future of the MiniMed brand following its separation from Medtronic. He highlights the importance of simplifying diabetes management through advanced technology, including artificial intelligence and user-friendly devices. Scott shares his personal journey with medical devices and his passion for improving patient care.

00:00 The Excitement of Innovation in Diabetes Care
07:56 Future Innovations and Technology in Diabetes Management
11:53 Insights from the Scientific Sessions
14:09 Personal Journey and Passion for Medical Devices


Medtronic is separating its diabetes business to and rebranding to MiniMed.
The company has a rich history of innovation spanning over 40 years.
MiniMed aims to simplify life with diabetes through advanced technology.
There is excitement around new products like InPen 2.0 and upgraded sensors.
The integration of artificial intelligence is crucial for future diabetes management.
Patients are responding positively to the new sensor technology.
Flexibility in treatment options is a key focus for MiniMed.
Scott's personal experience with medical devices drives his passion for innovation.
The future of diabetes care looks promising with ongoing advancements.
Scott emphasizes the privilege of working in medical technology that impacts lives.